Risk factors
Intensity Therapeutics (INTS) risk factors
Item 1A of every Intensity Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors56 risks5 new6 dropped8 reworded
Intensity Therapeutics faces severe financial and listing pressures, highlighted by a going concern warning, Nasdaq compliance notices, and ongoing operating losses.
Filed Mar 27, 2026 - FY2024 10-K risk factors57 risks
The company faces severe going concern doubts, zero product revenues, heavy reliance on a single intratumoral technology, and the need for substantial additional financing.
Filed Mar 13, 2025